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INTRODUCTION 
The duration and intensity of action of many drugs are largely 
determined by the speed at which they are metabolized in the body by 
enzymes in liver microsomes (1). Previous studies have shown that 
the activities of drug metabolizing enzymes in liver microsomes are 
markedly increased when animals are given various drugs, hormones, 
insecticides, and carcinogens� This increase in activity appears 
to represent an increased concentration of enzyme protein and is 
referred to as enzyme induction. Induction of liver microsomal 
enzymes leads to an accelerated biotransformation of drugs in vivo. 
This results in an· altered duration and intensity of drug action. 
l 
It has been reported that steroid hormones a,nd other body constituents 
are also substrates of drug metabolizing enzymes in liver microsomes 
(l). This indicates the administration of a hepatic microsomal 
enzyme inducer may stimulate the metabolism of natural body 
constituents. 
Richardson et al. (2) reported that 3-methylcholanthrene 
prevents 3'-methyl-4-dimethylaminoazobenzene, a potent carcinogen, 
from forming hepatomas in rats when both compounds are fed simulta­
neously� Brown, Miller, and Miller (3) provided an explanation for 
this observation when they showed that 3-methylcholanthrene increases 
the activity of the liver microsomal enzyme system that metabolizes 
aminoazo dyes to non-carcinogenic products. These investigations 
led to further studies of polycyclic hydrocarbons and other compounds 
that influence liver microsomal enzyme activity. 
2 
Conney and Burns ( 4) reported that pretreatment of rats with 
phenobarbital, barbital; aminopyrine, phenylbutazone, or orphenadrine 
enhances the activity of the azo dye demethylase system. It has been 
demonstrated that ·these drugs stimulate the activity of various 
other liver microsomal enzymes that metabolize zoxazolamine, 
phenylbutazone, hexobarbital, aminopyrine, and 3,4-benzpyrene (5). 
More than 200 drugs, insecticides, carcinogens, and oth_er chemicals 
are known to stimulate the activity of drug metabolizing enzymes 
located in the hepatic microsomes (1). 
'l'here appears to be a broad range of activity both with respect 
to the type of molecule which is able to elicit stimulation of hepatic 
microsomal activity and. with respect to the enzyme activities that are 
stimulated. Inducers are of at least two types, exemplified by 
phenobarbital and 3-methylcholanthrene. Compounds of the pheno-
-'! barbital type stimulate varied pathways of metabolism by liver 
microsomal enzymes, includ�ng oxidation and reduction reactions, 
glucuronide formation, and de-esterification. The phenobarbital type 
also increases microsomal protein content and alters the morphology 
of the agranular endoplasmic reticulum. Liver microsomes from 
phenobarbital treated rats show greater amino acid incorporating 
activity when measured in vivo ( 6) and in cell free preparations ( 7), 
and exhibit a greater sensitivity to stimulation by polyuridylic acid 
( 8) � The polycyclic aromatic hydrocarbons, typified by 3-methyl­
cholanthrene, stimulate a more limited group of reactions, do not 
affect microsomal protein content, nor do they affect gross morphologic 
changes in the agran ular endoplasmic reticulum ( 1) . 
3 
The two types of inducers differ in the course and intensity of 
induction. On daily administration of,phenobarbital to rats the 
maximal increase of enzyme activity (3- to 10-fold) is not reached 
for at least 3 days (5). After injecting polycyclic hydrocarbons 
the enzyme activity is more than doubled within 3 to 6 hours and 
maximal increases (5- to 10-fold) are observed after 24 hours (9,10) . 
The age of the patient is one of the factors that is considered 
when a drug is used in therapy. It is known that the young of man 
and animals are more sensitive to certain drugs than adults. This 
greater sensitivity could result from differences in drug metabolizing 
enzymes present in liver microsomes. Studies have shown that adults 
have liver microsomal enzyme activity which is several times higher 
than the activity present in the embryo (11)·. 
fouts and Adamson (11) reported that a number of drugs that are 
metabolized by enzymes present in liver microsomes of adult rabbits· 
are not metabolized by liver microsomes of newborn rabbits. There is 
some activity present two weeks after birth, and at the age of four 
weeks activity almost equals the adult level. The pathways studied 
include: oxidation of hexobarbital, N-dealkylation of aminopyrine, 
deamination of amphetamine, hyroxylation of acetanilide, oxidation of 
the ring sulfur of chlorpromazine, and the reduction of the nitro 
group of p-nitrobenzoic acid. When the supernatant fraction from· 
newborn rabbit livers is added to the reaction vessels containing 
adult liver homogenates, the adult enzymes are inhibited in some 
cases. This indicates the possible presence of inhibitors of drug 
metabolism in the livers of newborn rabbits. 
4 
Other studies also indicate differences between hepatic micro­
somal drug metabolizing enzymes present in newborn and adult animals. 
Jondorf et al. (12) reported that liver microsomes of newborn mice 
and guinea pigs are deficient in certain drug metabolizing enzymes. 
The enzyme systems that N-demethylates arninopyrine, 0-dealkylates 
phenacetin, oxidizes hexobarbital, and conjugates phenolphthalein as 
the glucuronide can not be demonstrated in newborn guinea pigs. The 
enzyme systems are absent 24 hours after birth but appear during the 
�irst week and increase in activity until the animals are about eight 
weeks old. Weatherall (13) reported that pentobarb�tal is more toxic 
to newborn than to adult rabbits and rats. It also produces'a more 
sustained pharmacologic effect in newborn animals as measured by loss 
of the righting reflex. 
ponney et a�. (5) reported that pretreatment of weanling rats 
with certain drugs causes a marked increase in the activity of various 
enzyme systems in hepatic microsomes. Inscoe and Axelrod (14) have 
shown that benzpyrene injected into newborn rats causes a significant 
increase in hepatic microsomal glucuronyl transferase as compared with 
untreated litter mates. They also reported that benzpyrene given to 
pregnant rats does not stimulate glucuronyl transferase in the fetus, 
though it does cause increased activity in the mother. Hart et al. ---
(15) reported that administration of sodium phenobarbital to pregnant 
does or to newborn from untreated does, stimulates hepatic microsomal 
drug metabolizing activity present in the newborn. Concurrent 
administration of ethionine blocked this increase in activity. 
Crigler and Gold (16) reported that the administration of 15 mg. 
5 
of phenobarbital removed the jaundice from two infants suffering from 
congenital nonhemolytic jaundice. Parallel studies on the metabolism 
of salicylate in these children showed a defective capacity to 
conjugate glucuronide. This defect did not exist when phenobarbital 
was being administered. This study suggests that enzyme inducers 
given to expectant mothers may have an effect on fetal liver microsomal 
enzyme activity. If enzymes can be induced in this manner it may be 
possible to treat congenital metabolic disorders resulting from the 
lack of certain enzyme systems by the administration of an enzyme 
inducer to the mother before delivery. 
The study of Hart et al. (15) indicates that pretreatment of 
pregnant rabbits with sodium phenobarbital stimulates microsomal 
enzyme activity in the offspring of these animals. A search of the 
literature uncovered no further studies using phenobarbital to 
stimulate fetal enzyme activity by pret!eating the mother. The fact 
that there are major differences in the hepatic microsomal enzyme 
activities of rats and rabbits along with the observation that 
benzpyrene causes no increase in activity in the offspring from 
pretreated pregnant rats (14) prompted our investigation of this 
phase of enzyme induction. 
Fouts and Brodie (17) were the first to report on the enzyme 
system which reduces p-nitrobenzoic acid in .liver microsomes. They 
found that this reductive system is located in both the microsomes 
and soluble fraction. It is now known that this system is located 
in the microsomes with only a trace of activity present in the soluble 
fraction (21, 18). This system was used in these experiments to 
determine the effect of sodium phenobarbital on the hepatic 
microsomal enzyme activity present in fetal and newborn from 
pretreated pregnant females. 
6 
MATERIAL AND METHODS 
Sprague-Dawley rats were used in this study. The animals were 
housed in an air-conditioned room (70-75°F) and provided with feed 
(Purina Laboratory Chow) and water ad libitum. 
7 
Sodium phenobarbital (30 mg./kg.) was dissolved in double distilled 
water and injected subcutaneously twice daily into pregnant rats. The 
injection schedule began approximately five days before delivery and 
continued throughout the experimental period. Some animals were given 
less than ten injections prior to delivery because the time of birth 
varied from 12 to 24 hours. A separ�te injection bottle containing 
the calculated dose in 0.2 ml. was prepared for each test animal. The 
control animals were given 0.2 ml. of double distilled water twice 
daily throughout the experimental period. 
The activity of the enzyme system which reduces p-nitrobenzoic 
acid top-aminobenzoic acid was determined using the method reported 
by Fouts and Brodie (17). During the four to five week experimental 
period the offspring were sacrificed by decapitation and-their livers 
removed. All subsequent tissue manipulation was carried out at Oto 4 
degrees centigrade. Livers were immediately weighed and homogenized 
with a Potter-Elvehjem Teflon-glass homogenizer in 4 parts of 0.2 M 
phosphate buffer, pH 7.4, to provide a 20 per cent homogenate. 
Duplicate 1.0 ml. (200 mg. of tissue) aliquots of homogenate were 
placed in 10 ml. beakers. The reaction beakers also contained 5.7 
micromoles of glucose-6-phosphate, 2.0 micromoles of adenosine 
triphosphate (NI1P), 0.25 micromoles of triphosphopyridine nucleotide 
(TPN), 0.3 micromoles of diphosphopyridine nucleotide (DPN), 100 
micromoles of nicotinamide, 20.0 micromoles of potassium chloride, 
8 
10.0 micromoles of magnesium chloride, 3.0 micromoles of p-nitrobenzoic 
acid and sufficient 0.1 M phosphate buffer, pH 7.4, to give a final 
volu.�e of 5 ml. This reaction system is similar to that used by 
Mueller and Miller ( 19). 
The reaction beakers were incubated for 2 hours in a Dubnoff 
metabolic shaker at 37 °c. in an atmosphere of nitrogen. At the end 
of the incubation period the reaction was stopped by the addition of 
15 ml. of 6.67 per cent trichloroacetic acid. The precipitated protein 
was removed by centrifugation at 3700g for 10 minutes and 5 ml. aliquots 
of the supernate were analyzed for p-aminobenzoic acid. 
The p-aminobenzoic acid present in the trichloroacetic acid 
supernates was diazotized and coupled as described by Bratton and 
Marshall ( 20). One ml. of freshly prepared sodium nitrit� (0. 1%) was 
added to the 5 ml. aliquot. After three minutes 1. 0 ml. of 0.5 per 
cent ammonium sulfamate was added to destroy excess nitrite. The 
diazotized product was coupled by adding 1 ml. of 0. 5 per cent 
N-(1-Naphthyl)-ethylenediarnine dihydrochloride, allowing fifteen 
minutes to complete the reaction. The colored derivative was 
extracted with 10 ml. of isoarnyl alcohol and assayed spectrophoto­
metrically on a Spectronic 20 at 540 mu. The reduction of p-nitobenzoic 
acid to p-aminobenzoic acid probably takes place in three stages, 
involving the intermediate forma�ion of nitroso and hydroxylamino 
compounds. There is no direct evidence indicating the presence of 
these intermediates, but Kamm (21) found that liver microsomes reduce 
'! 
nitrosobenzene and phenylhydroxylamine to aniline more rapidly than 
they do nitrobenzene. The probable pathway for the reduction of nitro 
groups by microsomal enzymes is the following (17): 
--) RN=O ---.>_;).. R-NHOH > 
Nitro Nitroso Hydroxy lanlino Amino 
The reactions involved in for�fng the colored derivative are the 
following: 
HOOC-o-NH2 + 
p-Aminobenzoic acid 
+ 
NaN02 
n
+ 
0 ) HOOC- '/_\ -N; 
Sodium nitrite 
+ + 
/; -�CH
2 
CH
2
NH
3 
2 2c1-
Diazonium intermediate 
Diazonium intermediate N-(1-Naphthyl)-ethylene­
diamine dihydrochloride 
Colored 
p1:oduct 
The following experiments were performed previous to studies 
using pregnant rats. 
An experiment was conducted to determine the relationship between 
tissue levels and the amount of p-aminobenzoic acid formed. The 
amount of p-aminobenzoic acid formed
_
by 100, 150, 200, and 300 milli­
grams of tissue was determined. Three reaction vessels for each tissue 
level.were prepared using a 20 per cent adult female liv�r homogenate. 
9 
10 
A control containing liver homogenate and all other ingredients except 
p-�itrobenzoic acid was also prepared. The results of this experiment 
are shown in Fig. 1. The results indicate that a di�ect relationship 
exists between the amount of tissue used and the amount of p-a.mino­
benzoic acid formed. The 200 mg. tissue level was used in all other 
parts of this study to measure the effect of sodium phenobarbital on 
the enzyme system which reduces p-nitrobenzoic acid. 
A test was performed to determine if the substrate was rate 
•limiting. Seven reaction vessels were prepared using 1 ml. of a 20 
per cent adult female liver homogenate and the previously list
0
ed 
ingredients. Three vessels contained six micromoles of p-nitrobenzoic 
acid, three contained three micromoles, and one served as a tissue 
blank. The same amount of p-aminobenzoic acid was formed in all 
reaction vessels containing substrate. This indicates that three 
_,I 
i micromoles of p-ni trobenzoic acid is not rate _limiting. 
A trial was conducted to determine the point at which the 
reaction is complete. Nine reaction vessels were prepared using 
200 mg. of tissue. Two reaction vessels were removed after 30, 
60, 90, 120, 150, and 180 minutes and assayed for p-aminobenzoic acid. 
The results of this trial are shown in Fig. 2. The results indicate 
that the reaction is essentially complete in 120 minutes. 
An experiment to determine the minimal dose of sodium 
phenobarbital capable of stimulating a significant increase in the 
activity of the enzyme system which reduces p-ni trobenzoic acid was 
conducted. Five groups, each containing three adult female rats, 
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Fig. 1. The activity of the enzyme system which reduces p-nitrobenzoic 
acid in adult female rats. One unit represents 0.1 micromole 
of p-ai�inobenzoic acid formed by 200 mg. of tissue in 2 hours. 
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Fig. 2. The activity of the enzyme system which reduces p-nitrobenzoic 
acid in adult female rats. One unit represents 0. 1 micromole 
of p-aminobenzoic acid formed by 200 mg. of tissue in 2 hours. 
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13 
were given sodium phenobarbital, dissolved in double distilled water, 
twice a day at different dosage levels. The results of this 
experiment are presented in Table 1. The administration of sodium 
phenobarbital 5 mg./kg. and 10 mg. /kg. did not significantaly 
stimulate p-nitrobenzoic acid reductase activity. A dose of 20 mg./kg. 
twice a day caused a 29 per cent increase while the 30 mg./kg. and 
40 mg./kg. dose increased activity by 176 and 243 per cent respectively. 
The dose of 30 mg. /kg. was used in all subsequent experiments in 
this study because it was the minimal c;lose which caused a significant 
increase in enzyme activity. The dose of 40 mg. /kg. stimulatetl the 
enzyme activity to a higher level, but also increased the possibility 
of causing fetal and newborn sedation. 
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TABLE I 
EFFECT OF SODIUM PHENOBARBITAL ON THE ACTIVITY 
OF THE ENZYME SYSTEM WHICH REDUCES 
p-NITROBENZOIC ACID IN THE 
ADULT FEMALE RAT� 
Enzyme Activity Per Cent 
Dose (micromoles of p-aminobenzoic of 
(mg. /kg.) acid formed per 200 mg. Control· 
tissue per 120 minutes). 
.25 
5 .25 100 
10 . 27 104 
20 . 35 129 
30 . 69 276 
40 . 95 343 
14 
Per Cent 
Change 
In 
Activity 
0 
4 
29 
176 
243 
15 
RESULTS 
Standard p-aminobenzoic acid curve •. An experiment to determine 
the relationship between the concentration of p-am�nobenzoic acid 
present in a 5 ml. aliquot of the trichloroacetic acid supernate and 
the optical density at 540 mu. was conducted. Reaction vessels 
containing the previously listed ingredients and concentrations of 
p-aminobenzoic acid ranging from Oto 1.2 micromoles were prepared. 
The vessels were incubated for two hours in an atmosphere of nitrogen. 
The reaction was then stopped by the addition of trichloroacetjc acid 
and 5 ml. aliquot samples were analyzed for p-aminobenzoic acid 
content by the previously described method. The results of this 
experiment are shown in Fig. 3. Each point on the curve represents 
the average value obtained from triplicate determinations from three 
trials. The results of this experiment indicate there is a direct 
relationship between the concentration of p-aminobenzoic acid and 
optical density in the range of Oto 1.2 micromoles. Enzyme 
activity is directly related to the a�ount of p-aminobenzoic acid 
formed, therefore, this curve was used to determine the results of 
this study. 
The influence of sodium phenobarbital on the hepatic microsomal 
enzyme system which reduces p-nitrobenzoic acid in newborn and fetal 
rats from pretreated pregnant females. To determine the effect of 
sodium phenobarbital pretreatment on newborn and fetal rats three 
pregnant animals were given subcutaneous injections of 30 mg./kg. 
twice daily beginning approximately five days before delivery and 
16 
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Fig. 3. Standard p-aminobenzoic acid curve. Optical density versus 
micromoles of p-aminobenzoic acid present in a 5 ml. aliquot. 
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continuing throughout the experimental period. The offspring were 
sacrificed at various intervals and their livers removed. Separate 
homogenates were prepared from male and female livers. The liver 
homogenates were tested for their ability to reduce p-nitrobenzoic 
acid to p-aminobenzoic acid. The results of these tests are presented 
in Fig. 4. Each point on the curve represents the average enzyme 
activity of groups of six rats. The level of activity present in 
male and female homoge�ates was equal at all times during devel�pment, 
therefore, a single curve was prepared. Enzyme activity is expressed 
as units. One unit equals 0.1 micromole of p-aminobenzoic acid 
produced by 200 mg. of tissue in two hours. 
The hepatic microsomal enzyme system which reduces p-nitrobenzoic 
acid is present 24 hours after birth. The activity rapidly increases 
to 33 per cent of the adult level in 14 days. The activity is equal 
to 75 per cent of the adult level at the age of 22 days and reaches 
the adult level at the age of 26 days. The offspring from sodium 
phenobarbital pretreated rats may have a more active p-nitrobenzoic 
acid reductase present at birth as indicated by a slightly higher 
level of activity during the first three days of life as compared to 
offspring from control animals. This increase in activity is apparently 
caused by sodium phenobarbital which reaches the fetus through the 
placenta. Tnere is a definite increase in activity of this system 
in offspring from pretreated females as indicated by the increased 
rate of development and the higher level of activity reached. Sodium 
phenobarbital in the mrunmillary secretion may be the cause of this 
increased activity. 
-
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Fig. 4. The effect of sodium phenobarbital on _the activity of the 
hepatic microsomal enzyme system which reduces p-nitrobenzoic 
acid in.fetal and newborn rats. One unit represents 0. 1 micro­
mole of p-aminobenzoic acid formed per 200 mg. of tissue in 2 
hours. A-activity of offspring from pretreated females, B­
normal adult activity, C-activity of control offspring, and 
D-activity of offspring receiving phenobarbital through milk. 
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The influence o� sodium phenobarbital 2,g_ the hepatic microsomal 
enzyme system which reduces p-nitrobenzoic acid in newborn rats 
receiving phenobarbital through the mother's milk. To determine the 
effect of sodium phenobarbital on newborn receiving this barbiturate 
through the mother's milk, female rats were given a dose of 30 mg./kg. 
by subcutaneous injection twice daily beginning on the day of delivery 
and continuing throughout the experimental period. The offspring 
were sacrificed and their hepatic microsomal enzyme activity determined. 
The results of these determinations are also shown in Fig. 4. The 
results indicate that the enzyme system which reduces p-nitrobenzoic 
acid in hepatic microsomes was stimulated in the offspring receiving 
phenobarbital through the milk. The enzyme activity is stimulated 
to the same extent, but develops at a slower ·rate than the activity 
present in offspring from rats that were given sodium phenobarbital 
during their pregnancy. 
20 . 
DISCUSSION 
This study was undertaken to obtain information on the influence 
of sodium phenobarbital on the hepatic microsomal enzyme system which 
reduces p-nitrobenzoic acid in fetal and newborn rats from pretreated 
females. The enzyme system in liver microsomes that catalyze the 
reduction of p-nitrobenzoic acid exhibited low activity in newborn 
rats and developed rapidly to �he adult level in four weeks. Results 
of this study indicate.that the administration of sodium phenobarbital 
(30 mg. /kg. ) to pregnant rats twice daily by subcutaneous injection 
beginning five days before delivery and continuing throughout· the 
experimental period stimulates the rate of development and increases 
the level of p-nitrobenzoic acid reductase twofold. Offspring from 
pretreated pregnant females .seem to have a slightly more active 
reductase system present at birth. Activity developed at a more rapid 
rate in offspring from pretreated females as compared with controls 
and offspring receiving phenobarbital through the mother's milk. 
The mechanism by which structually unrelated drugs, carcinogenic 
hydrocarbons, insecticides, and other compounds increase hepatic 
microsomal enzyme activity has been the subject of intensive research 
in recent years. It has been demonstrated that phenobarbital, 
chlordane, 3-methylcholanthrene, or 3 ,4-benzpyrene do not increase 
the activity of drug metabolizing enzymes when added to in vitro 
enzyme systems (5, 9, 10) . Phenobarbital administration increases the 
maximal velocity of ethylmorphine N-demethylation, chlorpromazine 
sulfoxidation, and hexobarbital oxidation, but does not influence the 
Michaelis constants or the susceptibility of the enzyme system to 
various inhibitors (22). This indicates the increased activity of 
hepatic microsomal enzymes from phenobarbital treated rats can not 
be explained by an altered affinity of enzyme for substrate. 
Several attempts to demonstrate that polycyclic hydrocarbons 
or phenobarbital enhance drug metabolizing activity by increasing 
. 21  
the level of an inhibitor have been unsuccessful (5,9,23). The 
discovery that certain compounds that inhibit the synthesis of protein 
also prevent drug induced increases in microsomal enzyme activity 
indicates increases in activity are related to an increased synthesis 
of enzyme protein. The stimulation of enzyme activity present in 
hepatic microsomes by 3-methylcholanthrene or phenobarbital is blocked 
by ethionine (5,9,10,24), puromycin (25,26) , or actinornycin D 
(26,27). It has been reported that these inhibitors block protein 
synthesis by different mechanisms. Ethionine blocks protein synthesis 
by lowering the level of ATP in the liver (28), puromycin blocks 
the transfer of soluble RNA-bound amino acid into microsomal 
protein (29) , and actinomycin D binds with DNA to block the 
DNA-directed synthesis of nuclear RNA which is required for protein 
synthesis (30). The inhibitory effect of ethionine on liver protein 
synthesis and the induction of increased drug metabolizing act-i vi ty 
in hepatic microsomes can be prevented in vivo by the administration 
of either ATP (28) or methionine (5,9,10). This suggests that 
adequate levels of S-adenosylmethionine may be important for the 
synthesis of microsomal enzymes. The blocking effect of 
actinomycin D suggests that phenobarbital and 3-methylcholanthrene 
may accelerate the DNA-directed synthesis of drug metabolizing 
enzymes on ribosomes. When puromycin, ethionine, or actinomycin D 
is administered several hours after 3-methylcholanthrene further 
increases in activity of aminoazo dye N-demethylase is prevented. 
This mey indicate the formation of a short lived messenger-RNA 
required for the increased synthesis of aminoazo dye N-demethylase 
(24,9). Loeb and Gelboin (31) reported that treatment of rats with 
3-methylcholanthrene increased the content of messenger-RNA in 
isolated liver nuclei and that nuclear RNA from treated rats was 
more active than equivalent amounts of RNA from normal rats in 
directing the incorporation of L-phenylalanine-c
1 4  
into protein 
in a cell free Escherichia coli system. Jervell et al. (32) 
confirmed the blocking action of ethionine, puromycin and 
actinomycin D on the induction of aminoazo dye N-demethylase by 
3-methylcholanthrene, but reported the induction of this enzyme 
by starvation is blocked by ethionine or puromycin but not by 
actinomycin D. This suggests the involvement of two different 
mechanisms. These authors also reported that i nduction of the 
N-demethylase system was blocked by the administration of glucose 
or fructose. 
The possibility that inducers of hepatic microsomal enzymes 
22 
may increase activity by stabilizing enzymes, as well as by 
accelerating their synthesis , is now being studied in several labora­
tories. Jick and Shuster (33, 34) found that treatment of mice with 
phenobarbital increases liver microsomal TPNH-cytochrome c reductase 
levels by increas ing its rate of synthesis and decreasing its rate 
of breakdown. These two workers also reported that phenobarbital 
increases total liver microsomal protein in rats by the same 
mechanism. Holtzman and Gillette (35) reported that phenobarbital 
inhibits the degradation of hepatic microsomal phospholipid in 
fasted rats. 
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Gelboin and Sokoloff (7) reported that the stimulatory effect 
of phenobarbital and 3-methylcholanthrene on the synthesis of 
microsomal enzymes and protein·· in vivo is paralled by increased 
incorporation of amino acids into microsomal protein in vitro. 
Phenobarbital produces a greater stimulation of amino acid 
incorporation into microsomal protein than does 3-methylcholanthrene. 
This agrees with the observation that phenobarbital stimulates 
more synthesis of microsomal protein in vivo than 3-methylcholanthrene 
( 25). Gelboin and Sokoloff (7) also reported that 3-methylcholanthrene 
stimulates the incorporation of soluble RNA-bound amino a�ids into 
liver protein in vitro. This indicates that it does not act on 
reactions leading to activation of amino acids but on steps between 
transfer-RNA and the formation of protein on ribosomes. These 
investigators suggest that the increase in amino acid incorporation 
induced by 3-methylcholanthrene is due , at least in part, to an 
increase in the number of active microsomal incorporation sites 
and an apparent increase in the messenger-RNA content of microsomes . 
Kato et al. (36) suggest that a portion of the greater amino .ac i d  
incorporating activity of mi crosomes from phenobarbital treated 
rats may be due to a phenobarbital induced shift to a greater 
proportion of membrane bound ribosomes . Kato et al. ( 37) showed 
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that treatment of rats with phenobarbital stimulates the incorporation 
of c14-leucine into microsomal protein in vivo but has no effect on 
the incorporation of this amino acid into protein in other sub­
cellular fractions. 
Treatment of rats with phenobarbital increased by 108 to 266 
per cent the incorporation of arginine, leucine , lysine , phenylalanine , 
and valine into liver microsomal protein in vitro. This effect could 
not be attributed to changes in cofactor level, amino acid con­
centration, or factors present in the cell sap. A fter the removal 
of endogenous messenger-RNA by incubation of the microsomes, the 
microsomes from phenobarbital treated rats displayed greater ability 
· 14 
to incorporate L-phenylalanine-C in the presence of either 
saturating or subsaturating amounts of polyuridylic acid . The 
ribosomes from phenobarbital treated and control rats have equal 
ability to incorporate this amino acid. This indicates that pheno­
barbital stimulated increases in microsomal enzyme activity are not 
directly related to alterations in the ribosomes, but suggests that it 
alters the translation of polyuridylic acid on the ribosomes (36). 
The ability of several stimulators of liver microsomal enzy�e 
activity to increase the concentrations of TPNH oxidase, TPNH­
cytochrome c reductase, and cytochrome P-450 in liver microsomes 
suggests that the induction of these electron transport . systems 
may play a role in the stimulatory effect of these compounds. 
This scheme is incomplete and cannot explain the selective effect 
of enzyme inducers that stimulate some liver microsomal hydroxyla­
tions without influencing others (1 ). 
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The results of this study indicate that a significant increase in 
activity of the hepatic microsomal enzyme system which reduces 
p-nitrobenzoic acid does not take place in offspring from sodium 
phenobarbital pretreated pregnant rats until the fifth day after 
delivery. This may be due to the limited capability of enzyme forming 
systems at this stage of development. It has been reported that the 
transformation of a normal li ver cell into a cancer cell is accompanied 
by a decrease of drug metabolizing activity (38, 39). It is of 
interest that hepatomas that resemble normal liver histologically 
and biochemically possess little or no microsomal drug metabolizing 
activity ( 38 , 39,40). Low levels of activity are also present in 
.regenerating liver (41,42,43). The limited capability of fetal 
and newborn (less than 5 days old) liver microsomal enzymes to be 
stimu).ated may result from a short supply of cofactors or the incomplete 
development of the endoplasmic reticulum or may involve other factors. 
Little work has been done in this area of study and as a result no 
comprehensive theory can be presented at this time. 
SUMMARY 
1. The method reported by Fouts and Brodie (17 ) was used to 
determine the effect of sodium phenobarbital on the activity of the 
liver microsomal enzyme system which reduces p-nitrobenzoic acid in 
fetal and newborn rats. 
2. Sodium phenobarbital (30 mg./kg. ) was given twice daily 
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by subcutaneous injection to pregnant rats beginning approximately 
five days before delivery and continuing throughout the experimental 
period. 
3. The liver microsomal enzyme system which reduces p-nitro­
benzoic acid developed at a more rapid rate and to a higher level of -
activity in offspring from pretreated females _ than in offspring 
from controls. 
4 .  The slightly more active reductase present at birth and 
the observation that offspring from pretreated pregnant rats 
, .  
develop activity faster than offspring given phenobarbital through 
the milk may indicate that some activity was induced in the fetus. 
5. The liver microsomal enzyme system which reduces 
p-nitrobenzoic acid is present in male and female rats at the 
same level of activity before and after reaching maturity. 
6 .  The inductive effect of sodium pheno:barbital ·on the 
enzyme system which reduce p-nitrobenzoic acid is the same in 
male and female rats. 
").,·-
I... 
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